- Home
- LPX vs IRTC Comparison
LPX vs IRTC Comparison
Compare LPX & IRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPX
- IRTC
- Stock Information
- Founded
- LPX 1973
- IRTC 2006
- Country
- LPX United States
- IRTC United States
- Employees
- LPX N/A
- IRTC N/A
- Industry
- LPX Forest Products
- IRTC Medical/Dental Instruments
- Sector
- LPX Basic Materials
- IRTC Health Care
- Exchange
- LPX Nasdaq
- IRTC Nasdaq
- Market Cap
- LPX 6.8B
- IRTC 5.8B
- IPO Year
- LPX N/A
- IRTC 2016
- Fundamental
- Price
- LPX $95.93
- IRTC $179.82
- Analyst Decision
- LPX Buy
- IRTC Strong Buy
- Analyst Count
- LPX 7
- IRTC 11
- Target Price
- LPX $111.43
- IRTC $163.82
- AVG Volume (30 Days)
- LPX 778.5K
- IRTC 389.1K
- Earning Date
- LPX 11-04-2025
- IRTC 10-29-2025
- Dividend Yield
- LPX 1.17%
- IRTC N/A
- EPS Growth
- LPX N/A
- IRTC N/A
- EPS
- LPX 4.23
- IRTC N/A
- Revenue
- LPX $2,880,000,000.00
- IRTC $657,227,000.00
- Revenue This Year
- LPX N/A
- IRTC $25.11
- Revenue Next Year
- LPX $7.88
- IRTC $16.65
- P/E Ratio
- LPX $22.73
- IRTC N/A
- Revenue Growth
- LPX N/A
- IRTC 22.37
- 52 Week Low
- LPX $78.82
- IRTC $55.92
- 52 Week High
- LPX $122.87
- IRTC $187.57
- Technical
- Relative Strength Index (RSI)
- LPX 50.88
- IRTC 63.32
- Support Level
- LPX $94.78
- IRTC $167.28
- Resistance Level
- LPX $97.88
- IRTC $187.57
- Average True Range (ATR)
- LPX 2.19
- IRTC 4.69
- MACD
- LPX -0.20
- IRTC 0.07
- Stochastic Oscillator
- LPX 44.56
- IRTC 65.09
About LPX Louisiana-Pacific Corporation
Louisiana-Pacific is primarily an oriented strand board producer and also offers engineered wood siding used in home construction and repair and remodel projects. The company is largely exposed to the North American housing market but has also established capacity in Brazil and Chile.
About IRTC iRhythm Technologies Inc.
iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.